Overview

Study of Bevacizumab With Different Manufacturing Process in Healthy Male Subjects

Status:
Recruiting
Trial end date:
2022-01-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetic similarity of bevacizumab with different manufacturing process in healthy male subjects. Another purpose is to determine safety, and immunogenicity of bevacizumab with different manufacturing process.
Phase:
Phase 1
Details
Lead Sponsor:
Innovent Biologics (Suzhou) Co. Ltd.
Treatments:
Bevacizumab